Skip to content
Governance Register

← US public companies

Verona Pharma plc

SEC CIK 1657312 · VRNA · last insider filing 2025-10-08

Directors (from insider filings)

NameCapacity as filedFilings
Ebsworth David R Director filed 2021 - 2025
Shah Mahendra Director filed 2021 - 2025
Sinha Vikas Director filed 2021 - 2025
Zaccardelli David Director · President and CEO filed 2021 - 2025
Edwards Martin Director filed 2021 - 2025
Ackermann Christina Director filed 2023 - 2025
Ullman Anders Director filed 2021 - 2025
Cunningham Kenneth Director filed 2021 - 2025
Deschamps Lisa Director filed 2021 - 2025
Brady James Aloysius Director filed 2022 - 2025
Austwick Michael Director filed 2024 - 2025
Orbimed Advisors LLC Director filed 2021 - 2023
Gupta Rishi Director filed 2021 - 2023
Orbimed Capital GP VI LLC Director filed 2021 - 2023
Sinclair Andrew Director filed 2021 - 2021

Officers (from insider filings)

NameTitle as filedFilings
Hahn Mark W Chief Financial Officer filed 2021 - 2025
Rickard Kathleen A. Chief Medical Officer filed 2021 - 2025
Fisher Andrew General Counsel filed 2024 - 2025
Poll Claire General Counsel filed 2021 - 2024

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.